Federated Hermes’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Sell |
737,369
-186
| -0% | -$2.61K | 0.02% | 566 |
|
|
2025
Q1 | $11.5M | Buy |
737,555
+244,633
| +50% | +$3.83M | 0.02% | 527 |
|
|
2024
Q4 | $6.87M | Sell |
492,922
-8,909
| -2% | -$124K | 0.02% | 635 |
|
|
2024
Q3 | $4.67M | Buy |
501,831
+151,717
| +43% | +$1.41M | 0.01% | 729 |
|
|
2024
Q2 | $3.26M | Hold |
350,114
| – | – | 0.01% | 812 |
|
|
2024
Q1 | $3.47M | Sell |
350,114
-171,355
| -33% | -$1.7M | 0.01% | 805 |
|
|
2023
Q4 | $1.68M | Buy |
521,469
+461,469
| +769% | +$1.49M | ﹤0.01% | 1000 |
|
|
2023
Q3 | $319K | Buy |
60,000
+20,000
| +50% | +$106K | ﹤0.01% | 1453 |
|
|
2023
Q2 | $381K | Buy |
40,000
+10,000
| +33% | +$95.3K | ﹤0.01% | 1449 |
|
|
2023
Q1 | $330K | Buy |
30,000
+6,000
| +25% | +$66K | ﹤0.01% | 1504 |
|
|
2022
Q4 | $355K | Buy |
+24,000
| New | +$355K | ﹤0.01% | 1441 |
|